Immunomedics (IMMU) - moderated | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Immunomedics (IMMU) - moderated

An SI Board Since September 2006

Posts	SubjectMarks	Bans	Symbol
63363	356	15	IMMU

Emcee: idahoranch1	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
62518	SAVA Director Rick Barry sent this to Joe: [graphic] [graphic]	ghettogoulash	1	4/12/2024
62517	Awesome interview. This is the first we have heard anything from the vilified Dr	ghettogoulash	-	4/10/2024
62516	It's VERY good. He is a very successful 47 year old who is now independentl	plhky3465	2	4/10/2024
62515	just finished over an hour of the interview......very compelling. Matt is the si	scorman1	-	4/9/2024
62514	We hold a lot of it. I expect them to be taken out by one of the drugmakers tha	kdd999	-	4/9/2024
62513	Did anyone else see Joe Springer’s YouTube presentation today featuring Matt Nac	Gotrodelvy	-	4/9/2024
62512	Jan '25 Calls are super cheap. They won't be for long. The massive buyin	ghettogoulash	-	4/9/2024
62511	Great entry point here on ENVX, near an all-time low after going public in 2021.	ghettogoulash	1	4/9/2024
62510	I'm still sitting on my underwater position in SAVA. It's small enough	stockdoc77	3	4/6/2024
62509	[graphic] bluebird bio, Inc. (NASDAQ:BLUE) Q4 2023 Earnings Call Transcript fina	dorightbythem	2	4/4/2024
62508	Anyone here invested in CRIS? Less than 5.9 million shares outstanding. Big mov	IMMUzombie	-	4/4/2024
62507	OT Anyone know of a good AI board on Silicon Investor or elsewhere?	sysiphus	1	4/4/2024
62506	To clarify the issue of an appeal, Cassava was given leave to amend its complain	Fitzhughlaw	4	4/2/2024
62505	CASSAVA'S LIBEL LAWSUIT DISMISSED. Here's a good summary of the federal	Fitzhughlaw	4	4/2/2024
62504	OT rant about financial reporting. There's an old joke that goes something	erickerickson	-	4/1/2024
62503	Much appreciated! I have taken a very small (as you would say token) position,	Davidoff	-	3/28/2024
62502	I’ve had a small (almost token) position for a year and a half. I’ve been waitin	Olecranon	-	3/28/2024
62501	BCRX Anyone follow Biocryst Pharma? It is a large holding of both Capt. B. and	Davidoff	2	3/28/2024
62500	ADAP Being published in The Lancet: thelancet.com Authors seem confident in ap	IMMUzombie	1	3/27/2024
62499	no Erick, it was another great misstep. The DSMB was instructed NOT to review ef	scorman1	2	3/26/2024
62498	bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Opera	dorightbythem	1	3/26/2024
62497	SAVA: Cassava Sciences Announces Completion of an Interim Safety Review of Oral	erickerickson	3	3/25/2024
62496	Heavy into AADI with you. Hoping that Dr B magic can work again...	sukit	1	3/25/2024
62495	Thanks. That one made up for a number of...er...not-so-great decisions... While	erickerickson	1	3/24/2024
62494	finance.yahoo.com Congrats to all who held. I sold out around $17 and went hea	summer_sky	4	3/23/2024

Go to reply# or date (mm/dd/yy):